{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:13:41Z","timestamp":1761862421968,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.medcli.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T07:31:19Z","timestamp":1700724679000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-6142","authenticated-orcid":false,"given":"Felipe B.","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-1752","authenticated-orcid":false,"given":"Francisco Wilker Mustafa Gomes","family":"Muniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-5728","authenticated-orcid":false,"given":"Gdayllon C.","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-7415","authenticated-orcid":false,"given":"Karine C.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2044-0779","authenticated-orcid":false,"given":"Carolyne N.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-8068","authenticated-orcid":false,"given":"Andr\u00e9 P.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1490-2393","authenticated-orcid":false,"given":"Jos\u00e9 Carlos R.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4435-0614","authenticated-orcid":false,"given":"Tain\u00e1","family":"Veras de S. Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-1523","authenticated-orcid":false,"given":"Pedro Felipe C.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-3164","authenticated-orcid":false,"given":"Eanes Delgado B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-1738","authenticated-orcid":false,"given":"Elizabeth de F.","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-5481","authenticated-orcid":false,"given":"Reinaldo B.","family":"Ori\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.10.004_bib0125","unstructured":"Weekly epidemiological update on COVID-19-4. 2022. Available from https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---4-may-2022 [accessed 8.7.22]."},{"key":"10.1016\/j.medcli.2023.10.004_bib0130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.10.004_bib0135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardio"},{"key":"10.1016\/j.medcli.2023.10.004_bib0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. 2020","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.medcli.2023.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.medcli.2023.10.004_bib0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.medcli.2023.10.004_bib0155","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2023.10.004_bib0160","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1038\/s41598-022-07918-6","article-title":"ACE2 protein expression in lung tissues of severe COVID-19 infection","volume":"12","author":"Gheware","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.medcli.2023.10.004_bib0165","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/imj.15078","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19","volume":"50","author":"Covino","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.medcli.2023.10.004_bib0170","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520979151","article-title":"Impact of renin\u2013angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study","volume":"48","author":"Zhong","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.medcli.2023.10.004_bib0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, much more than just a receptor for SARS-COV-2","volume":"10","author":"Samavati","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.medcli.2023.10.004_bib0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: the major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.medcli.2023.10.004_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.medcli.2023.10.004_bib0190","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2023.10.004_bib0195","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/jmv.26139","article-title":"Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection","volume":"92","author":"Zhuang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.medcli.2023.10.004_bib0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2023.10.004_bib0205","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.medcli.2023.10.004_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2023.10.004_bib0215","doi-asserted-by":"crossref","first-page":"e019669","DOI":"10.1161\/JAHA.120.019669","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use and covid-19 infection among 824 650 patients with hypertension from a us integrated healthcare system","volume":"10","author":"An","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2023.10.004_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.medcli.2021.04.005","article-title":"Chronic use of renin\u2013angiotensin\u2013aldosterone inhibitors in hypertensive COVID-19 patients: results from a Spanish registry and meta-analysis","volume":"158","author":"Aparisi","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2023.10.004_bib0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/postgradmedj-2021-140674","article-title":"Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study","volume":"98","author":"Chen","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.medcli.2023.10.004_bib0230","doi-asserted-by":"crossref","DOI":"10.1177\/23337214211057392","article-title":"Factors associated for mortality of older people with COVID 19: a systematic review and meta-analysis","volume":"7","author":"Damayanthi","year":"2021","journal-title":"Gerontol Geriatr Med"},{"key":"10.1016\/j.medcli.2023.10.004_bib0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13098-020-00586-4","article-title":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis","volume":"12","author":"De Almeida-Pititto","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.medcli.2023.10.004_bib0240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J Card Fail"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300605X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300605X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:57:03Z","timestamp":1758419823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577532300605X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S002577532300605X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.10.004","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}